- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Positron hits the ropes
PET vendor Positron could be headed for bankruptcy. An independent auditor has expressed "substantial doubt" that the company, which was among the pioneers of positron imaging, could continue much longer as a "going concern." The auditor's comments were
PET vendor Positron could be headed for bankruptcy. An independent auditor has expressed "substantial doubt" that the company, which was among the pioneers of positron imaging, could continue much longer as a "going concern." The auditor's comments were reported in Positron's annual report, filed March 29 with the Securities and Exchange Commission. As of Dec. 31, 2001, the company had cash and cash equivalents of $635,000 compared with cash and cash equivalents and short-term investments of $2,201,000 a year earlier. Positron has accumulated a deficit of more than $54 million since its inception in 1983, according to the auditor's statement. Only about 19 of the company's Posicam PET scanners are currently in operation, 15 of them in the U.S. The company must increase system sales to become profitable, something it has not been able to do in its 20-year history, or obtain additional capital, according to the auditor.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
